Contreversy exists as to whether a screening programme for ovarian cancer is merited on a population basis. However, there are some recognised familial syndroems that definitely predispose to the development of the disease (e.g. the possession of the BRCA mutated gene in the genome) and such patients must be surveyed carefully with regular scans, or even undergo prophylactic oophorectomy (bilateral).